Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
977
Sort by:
Hepatitis B Vaccine Market - Forecast from 2026 to 2031
US$ 3,950.00
The Hepatitis B vaccine market, with a 5.49% CAGR, is expected to grow to USD 10.767 billion in 2031 from USD 7.813 billion in 2025. The hepatitis B vaccine market is a critical and mature segment wit...
January 2026
149 pages
Polio Vaccine Market - 2025-2033
US$ 3,400.00
Polio Vaccine Market reached US$ 804.77 million in 2024 and is expected to reach US$ 1,249.17 million by 2033, growing with a CAGR of 5.60% during the forecast period 2026-2033. The Polio Vaccine Mark...
December 2025
39 pages
Microneedle Flu Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Solid Microneedle, Hollow Microneedle), By Vaccine Type (Trivalent Flu Vaccine, Quadrivalent Flu Vaccine), By Region, By Competition, 2020-2030F
US$ 4,500.00
The Global Microneedle Flu Vaccine Market, valued at USD 1.18 Billion in 2024, is projected to experience a CAGR of 5.96% to reach USD 1.67 Billion by 2030. The global microneedle flu vaccine is an in...
December 2025
186 pages
Rabies Vaccine Market By Product Type (Chick Embryo Cells Rabies Vaccine, Vero Cell Rabies Vaccine, Human Diploid Cell Vaccine, Human Rabies Immune Globulin (HRIG), Others), By Prophylaxis Type (Pre-exposure prophylaxis, Post-exposure prophylaxis), By Application (Human, Animal), By End User (Hospitals, Veterinary clinics, Others): Global Opportunity Analysis and Industry Forecast, 2025-2034
US$ 2,655.00
The rabies vaccine market was valued at $1,319.90 million in 2024 and is estimated to reach $2,041.90 million by 2034, exhibiting a CAGR of 4.5% from 2025 to 2034. Rabies remains a significant public...
December 2025
319 pages
Animal Anti-rabies Vaccine Market - 2026-2031
US$ 3,400.00
Animal Anti-rabies Vaccine Market reached US$ 464.14 million in 2023 and is expected to reach US$ 646.98 million by 2031, growing with a CAGR of 4.20% during the forecast period 2026-2031. The Animal...
November 2025
52 pages
Adult Vaccines Market Outlook 2025-2034: Market Share, and Growth Analysis By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines), By Application, By End Users
US$ 3,950.00
The Adult Vaccines Market is valued at USD 20.6 billion in 2025 and is projected to grow at a CAGR of 8.6% to reach USD 43.1 billion by 2034.The Adult Vaccines Market is a specialized sector focused o...
October 2025
160 pages
Travel Vaccines Market Outlook 2025-2034: Market Share, and Growth Analysis By Disease (Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,), By Composition (Mono Vaccines, Combination Vaccines), By Booking Channel, By Application
US$ 3,950.00
The Travel Vaccines Market is valued at USD 6.5 billion in 2025 and is projected to grow at a CAGR of 9.7% to reach USD 14.9 billion by 2034.The Travel Vaccines Market is a critical component of globa...
October 2025
160 pages
Chickenpox Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis By Vaccine (Monovalent varicella vaccine, Combination varicella vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Chickenpox Vaccination), By End-Users
US$ 3,950.00
The Chickenpox Vaccine Market is valued at USD 4.5 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 8.6 billion by 2034.The chickenpox vaccine market plays a vital role in globa...
October 2025
160 pages
Human Papillomavirus (Hpv) Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Tetravalent, Nonavalent, Bivalent), By Disease Indication (Cervical Cancer, Anal Cancer, Vulvar And Vaginal Cancer, Penile Cancer, Oropharyngeal Cancer, Other Indications), By Distribution Channel, By Industry Vertical
US$ 3,950.00
The Human Papillomavirus (Hpv) Vaccine Market is valued at USD 8.2 billion in 2025 and is projected to grow at a CAGR of 14.1% to reach USD 26.8 billion by 2034.The Human Papillomavirus (HPV) Vaccine...
October 2025
160 pages
Plant-Based Vaccines Market Outlook 2025-2034: Market Share, and Growth Analysis By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application
US$ 3,950.00
The Plant-Based Vaccines Market is valued at USD 2.1 billion in 2025 and is projected to grow at a CAGR of 10.7% to reach USD 5.2 billion by 2034. Plant-Based Vaccines Market Overview The plant-based...
October 2025
160 pages
Quadrivalent Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Intradermal Shot, Intramuscular Injection, Nasal Spray), By Technology (Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies), By Disease, By Age Group, By Distribution Channel
US$ 3,950.00
The Quadrivalent Market is valued at USD 11.4 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 23.6 billion by 2034. Market Overview The global quadrivalent vaccine market has e...
October 2025
160 pages
Respiratory Disease Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections), By Age, By End-User
US$ 3,950.00
The Respiratory Disease Vaccine Market is valued at USD 57.3 billion in 2025 and is projected to grow at a CAGR of 2.5% to reach USD 71.3 billion by 2034.The Respiratory Disease Vaccine Market has bec...
October 2025
160 pages
Global Therapeutic Vaccines Market Growth 2025-2031
US$ 3,660.00
The global Therapeutic Vaccines market size is predicted to grow from US$ 52540 million in 2025 to US$ 167680 million in 2031; it is expected to grow at a CAGR of 21.3% from 2025 to 2031. The impact o...
October 2025
94 pages
Global Human Combination Vaccines Market Growth 2025-2031
US$ 3,660.00
The global Human Combination Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
105 pages
Global H1N1 Vaccines Market Growth 2025-2031
US$ 3,660.00
The global H1N1 Vaccines market size is predicted to grow from US$ 4903 million in 2025 to US$ 5946 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031. The impact of the lates...
October 2025
104 pages
Global HPV Vaccines Market Growth 2025-2031
US$ 3,660.00
The global HPV Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff m...
October 2025
86 pages
Global MMR Vaccines Market Growth 2025-2031
US$ 3,660.00
The global MMR Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff m...
October 2025
84 pages
Global Rotavirus Infections Drug Market Growth 2025-2031
US$ 3,660.00
The global Rotavirus Infections Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
91 pages
Global Tick-borne Encephalitis Vaccine Market Growth 2025-2031
US$ 3,660.00
... forecast to 2023. To understand the structure of Tick-borne Encephalitis Vaccine market by identifying its various subsegments. Focuses on the key global Tick-borne Encephalitis Vaccine manufacturers, to define, describe and analyze the ...
October 2025
82 pages
Global DT-Based Combined Vaccines Market Growth 2025-2031
US$ 3,660.00
The global DT-Based Combined Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
106 pages
Global Human Tetanus Immunoglobulin Market Growth 2025-2031
US$ 3,660.00
The global Human Tetanus Immunoglobulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the late...
October 2025
101 pages
